KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Change in Cash (2016 - 2025)

Historic Change in Cash for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $113.0 million.

  • Quest Diagnostics' Change in Cash fell 7707.91% to $113.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$332.0 million, marking a year-over-year decrease of 15346.22%. This contributed to the annual value of -$137.0 million for FY2024, which is 13692.72% down from last year.
  • Latest data reveals that Quest Diagnostics reported Change in Cash of $113.0 million as of Q3 2025, which was down 7707.91% from $131.0 million recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Change in Cash peaked at $543.0 million during Q4 2023, and registered a low of -$670.0 million during Q2 2021.
  • Its 5-year average for Change in Cash is -$38.2 million, with a median of -$90.0 million in 2022.
  • In the last 5 years, Quest Diagnostics' Change in Cash tumbled by 32222.22% in 2022 and then surged by 280000.0% in 2024.
  • Quest Diagnostics' Change in Cash (Quarter) stood at -$115.0 million in 2021, then plummeted by 234.78% to -$385.0 million in 2022, then soared by 241.04% to $543.0 million in 2023, then plummeted by 139.59% to -$215.0 million in 2024, then surged by 152.56% to $113.0 million in 2025.
  • Its Change in Cash stands at $113.0 million for Q3 2025, versus $131.0 million for Q2 2025 and -$361.0 million for Q1 2025.